US regulators take aim at high-profile mergers, but smaller deals abound

April 12, 2016 | Analyst Insight

While observers see merger and acquisition activity ticking up to near-record levels, with chemicals and pharmaceutical companies following the larger trend, large U.S. related mergers are facing sometimes fatal...